Leeds Steven G, Burdick J S, Ogola Gerald O, Ontiveros Estrellita
Division of Minimally Invasive Surgery (Leeds, Ontiveros) and Division of Gastroenterology (Burdick), Baylor University Medical Center at Dallas; and Center for Clinical Effectiveness, Baylor Scott & White Health, Dallas, Texas (Ogola).
Proc (Bayl Univ Med Cent). 2017 Oct;30(4):419-423. doi: 10.1080/08998280.2017.11930212.
Achalasia is a rare disorder that has several treatment options. The gold standard of treatment is a surgical myotomy called a laparoscopic Heller myotomy (LHM). More recently, an endoscopic myotomy has become an option as well, called per-oral endoscopic myotomy (POEM). An achalasia registry was queried for patients undergoing either LHM or POEM at Baylor University Medical Center at Dallas. Patient demographics, preoperative and postoperative data points, and Eckardt scores were collected. The patients were further stratified into their follow-up intervals, immediate postoperative and long-term follow-up, to assess surgical success. A subset analysis was done for success of treatment for patients who had redo surgery versus those undergoing the procedure for the first time. There were 12 patients in the POEM group and 11 patients in the LHM group. Both groups demonstrated mean lower esophageal sphincter pressures with failure to relax. Procedure length and hospital length of stay were similar between the two groups. There were three adverse events in each group, but none altered the patient's postoperative clinical course. Eckardt scores, used to assess success of the surgery, were 82% for POEM patients and 66% for LHM patients after 6 months. The outcomes for POEM and LHM in our early experience are similar to those reported in the literature for high-volume centers managing achalasia.
贲门失弛缓症是一种罕见的疾病,有多种治疗选择。治疗的金标准是一种名为腹腔镜Heller肌切开术(LHM)的手术肌切开术。最近,一种内镜下肌切开术也成为了一种选择,即经口内镜下肌切开术(POEM)。我们查询了达拉斯贝勒大学医学中心接受LHM或POEM治疗的贲门失弛缓症患者登记资料。收集了患者的人口统计学数据、术前和术后数据点以及埃卡德特评分。患者被进一步分层为术后即刻和长期随访的随访间隔,以评估手术成功率。对接受再次手术的患者与首次接受该手术的患者的治疗成功率进行了亚组分析。POEM组有12例患者,LHM组有11例患者。两组均显示食管下括约肌平均压力且不能松弛。两组的手术时间和住院时间相似。每组有3例不良事件,但均未改变患者的术后临床病程。用于评估手术成功率的埃卡德特评分在术后6个月时,POEM患者为82%,LHM患者为66%。我们早期经验中POEM和LHM的结果与文献中报道的高容量中心治疗贲门失弛缓症的结果相似。